on Comparative, non-randomized study for Androgenetic Alopecia
Not Applicable
- Conditions
- Health Condition 1: L649- Androgenic alopecia, unspecified
- Registration Number
- CTRI/2022/12/048074
- Lead Sponsor
- A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All patients clinically diagnosed as androgenic alopecia Norwood Hamilton grades III â?? V or Ludwigs II- III (in case of female pattern hair loss)
Age above 25 yrs with active hair loss in the past 6 months
Should have adequate adipose tissue for syringe based lipoharvest
Patients willing to undergo procedure after a written informed consent and complete blood check up with serology
Who have not undergone any interventional procedures up till now over scalp
Exclusion Criteria
Not willing to undergo the procedures
Any abnormality in coagulation profile and serology
Diabetes, hypertension and any other significant comorbidities (clinically significant medical / psychiatric illness)
With active infection/ inflammation/ auto immune focus
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in Androgenetic alopecia and Female patterned hair loss assessed by trichoscopic parameters Baseline, 3 months and 6 months after the administration of Autologous SVF and post scalp threads in patients who have undergone SVFTimepoint: After 6 months
- Secondary Outcome Measures
Name Time Method To assess the efficacy of SVF in androgenetic alopecia after 3 months <br/ ><br>To assess the superiority of combination of scalp threads and SVF over individual modalities.Timepoint: After 3 months <br/ ><br>After 6 months